ArticleCancer chemotherapy and pharmacology2014

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors.

Autumn J McRee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.